MedTrace Logo

Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome

NCT07320612 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-01-06

No results posted yet for this study

Summary

To compare efficacy and safety of Azithromycin versus control in children with steroid sensitive nephrotic syndrome

Conditions

  • Nephrotic Syndrome

Interventions

DRUG

Azithromycin and steroids

80 children will be assigned group A and children will be given Azithromycin along with standard course of steroids.

DRUG

steroids

80 children will be assigned group B and will be given only standard course of treatment

Sponsors & Collaborators

  • University of Child Health Sciences and Children's Hospital, Lahore

    lead OTHER

Principal Investigators

  • Dr. Ummara Subhani, MD · UCHS Lahore

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-08
Primary Completion
2025-08-08
Completion
2025-10-08

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07320612 on ClinicalTrials.gov